SPY442.82-2.92 -0.66%
DIA346.10-1.35 -0.39%
IXIC15,064.56-117.37 -0.77%

Rain Therapeutics To Present At IASLC 2021 World Conference On Lung Cancer And Participate In Panel Discussion At Citi 16th Annual Biopharma Virtual Conference

Rain Therapeutics Inc. (NASDAQ:RAIN), ("Rain"), a late-stage company developing precision oncology therapeutics, today announced it will be presenting a poster at the virtual IASLC 2021 World Conference on Lung

Benzinga · 09/01/2021 08:02

Rain Therapeutics Inc. (NASDAQ:RAIN), ("Rain"), a late-stage company developing precision oncology therapeutics, today announced it will be presenting a poster at the virtual IASLC 2021 World Conference on Lung Cancer (#WCLC21) being held September 8-14, 2021. Avanish Vellanki, co-founder, chairman and chief executive officer of Rain, will also participate in a Targeted Oncology Panel Discussion at the Citi 16th Annual Biopharma Conference being held September 8-10, 2021.
 

Additional details can be found below:

IASLC 2021 World Conference on Lung Cancer

Poster Title: The MDM2/p53 axis is a therapeutic vulnerability in malignant pleural mesothelioma

Presenter: Lynn Heasley, Ph.D., University of Colorado Anschutz Medical Campus

United States of America

Date: Wednesday, September 8, 2021

Citi 16th Annual Biopharma Virtual Conference Targeted Oncology Panel Discussion

Date: Friday, September 10, 2021

Time: 6:45 – 7:30 a.m. PT

Location: Company's website (click here)